Sertraline

Verify with FDA CVM →

36 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
36
Total Reports
0
Deaths Reported
0.0%
Death Rate

Active Ingredients

Sertraline

Administration Routes

UnknownOral

Species Affected

Dog 19
Human 15
Unknown 1
Cat 1

Most Affected Breeds

Unknown 16
Retriever - Labrador 3
Terrier - Boston 2
Dog (unknown) 2
Crossbred Canine/dog 2
Chihuahua 2
Pit Bull 1
Patterdale Terrier 1
Shih Tzu 1
Retriever - Nova Scotia Duck Tolling 1

Most Reported Reactions

Accidental exposure 8
Lack of efficacy - NOS 6
Skin disorders NOS 2
Itching 2
Shaking 2
Dizziness 2
Aggression 2
Seizure NOS 2
Skin swelling 2
Warm feeling to the touch 2
Fever 2
Welt 2

Outcome Breakdown

Outcome Unknown
16 (45.7%)
Ongoing
10 (28.6%)
Recovered/Normal
8 (22.9%)
Recovered with Sequela
1 (2.9%)

Data Summary

Metric Value
Total adverse event reports 36
Reports involving death 0
Case-fatality rate (reported events) 0.0%
Distinct species in reports 4
Distinct breeds in reports 15
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Sertraline Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 36 adverse event reports referencing Sertraline, including 0 reports in which the animal died — a 0.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Sertraline. Reported administration routes include Unknown, Oral. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Sertraline reports are Dog (19 reports), Human (15 reports), Unknown (1 reports), with Dog accounting for the largest share. Within those species, Unknown (16), Retriever - Labrador (3), Terrier - Boston (2) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Sertraline are Accidental exposure (8), Lack of efficacy - NOS (6), Skin disorders NOS (2), Itching (2). Of the 35 reports with a coded outcome, Outcome Unknown is the leading category at 45.7%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Sertraline.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial